Investor appetite for AI-enabled drug discovery growing in China: Insilico founder

Investor appetite for AI-enabled drug discovery growing in China: Insilico founder

Alex Zhavoronkov, founder and CEO of Hong Kong-based Insilico Medicine

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter